Editorial_Board
Editors-in-Chief Roger J. Bedimo, MD, is the Chief of Infectious Diseases Section at the VA North Texas Health Care System and Professor of Medicine at th
Editors-in-Chief Roger J. Bedimo, MD, is the Chief of Infectious Diseases Section at the VA North Texas Health Care System and Professor of Medicine at th
This pharmacokinetic study of sofosbuvir/velpatasvir found no clinically meaningful difference in drug exposure in pregnant versus non-pregnant women. Sofo
We used a One Health approach to study Texas dairy farms where cattle were suffering infections with HPAI H5N1 avian influenza A virus. In addition…
The Centers for Medicare & Medicaid Services recently included a new add-on code for infectious disease physicians in its 2025 Medicare Physician Fee Schedule Final…
Support our cause by donating to 2024 Giving Tuesday.
The Antimicrobial Stewardship Centers for Excellence (CoE) Program promotes excellence in antimicro bial use and combating antimicrobial resistance by recognizing hospitals that effectively demonstrate excellence…
Higher metabolic burden, particularly diabetes, was associated with greater risk for liver and nonliver complications in patients with chronic hepatitis B.
Ana P. Velez, MD, FACP, answered questions about her path to ID, how she blends art and science and why she supports the IDSA Foundation.
Michael A. Horberg, MD, MAS, FIDSA, and Melanie Thompson, MD, answer questions about HIVMA’s and IDSA’s updated guidance for primary care for people with HIV.
A financial incentive to provide a rationale to not prescribe antibiotics to children with acute respiratory or gastrointestinal infections in Japan was as